Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2018

View Archived Issues

Interneurons to the spinal cord rescue

Kinase inhibitor restores chemo sensitivity

Selective SSTR4 receptor agonist presented for the treatment of Alzheimer's disease

New phase IIa study aims to confirm absence of anticholinergic effects with seliforant

BDNF gene therapy shows promising preclinical results and prepares for clinical trials

FDA approves Orilissa for moderate to severe endometriosis pain

RORgammaT antagonists described by Kaken Pharmaceutical, Meiji Seika Pharma

Aldeyra opens phase III trial of topical reproxalap to treat ichthyosis in Sjogren-Larsson syndrome

SSAO inhibitors identified at Ube Industries

Purdue Pharma patents mu-opioid receptor and/or kappa-opioid receptor agonists

Shanghai Longwood Biopharmaceuticals presents agents for HBV infection

Roche, Genentech describe new JAK1 inhibitors

Biohaven begins phase II/III study of trigriluzole for mild to moderate Alzheimer's disease

Sienna reports phase Ib maximal use safety data on SNA-120 for pruritus in psoriasis

FDA accepts Celyad's IND for non-gene edited allogeneic CAR-T candidate CYAD-101

Stress-induced depression depends on innate immunity

Minomic completes dosing in first-in-human study of miltuximab

KEYNOTE-48 trial of Keytruda meets OS primary endpoint in head and neck cancer

Novel gene therapy demonstrates efficacy in preclinical models of neurodegenerative disease